Snakebite antivenom study
Part of Injuries & trauma clinical trials.
This study is testing a new polyvalent antivenom called Premium-PANAF for treating snakebites in Ethiopia. It aims to see how well the antivenom works for people who have been bitten by venomous snakes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been bitten by a venomous snake and are receiving the study antivenom Premium-PANAF.
- You have not received any other antivenom treatment for this snakebite.
- You are able to understand and sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks households about snakebites to understand where and how often they happen. Your participation helps researchers learn how to reduce snakebite risks.
This trial compares two methods of immobilizing a snake bite: a pressure pad versus a pressure bandage. It uses a harmless radioactive tracer in healthy volunteers to see which method works better.
This trial tests an oral medicine that may stop snake venom from spreading after a bite. It aims to see if this medicine can be taken safely at home, before reaching a hospital, to reduce the need for antivenom and improve outcomes.
This study is observing patients who have been bitten by a snake. It aims to learn more about the cases, how they are treated, and the outcomes to improve care for future snakebite patients in this region.
This study tests a new scoring system to predict how serious a snakebite is and what symptoms may develop. If you've been bitten by a snake in the last 24 hours, this study could help improve care for others like you.
This study tests a new AI system that uses photos of the snake to quickly identify the species and help doctors choose the right treatment. If you were bitten by a snake and have a clear picture of it, you may be able to join.
Hear when a new Snake Envenomation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.